GTx, Inc. (NASDAQ:GTXI)
A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
iceman7403
(58.79)
Submitted: 5/7/2007 5:50:39 PM :
Start Price:
$19.82
GTXI Score:
-77.26
great pipeline and collaborations with large pharmas
Recs
nilknarb194572
(< 20)
Submitted: 2/21/2007 12:42:39 PM :
Start Price:
$20.50
GTXI Score:
-81.15
This drug is presently being tested for the treatment of prostrate cancer.Eight months ago it was tested on my friend along with a sugar pill the cancer is gone.I'm sure this drug is going to be around for a while.
Recs
aasp
(< 20)
Submitted: 1/5/2007 10:25:06 PM :
Start Price:
$16.36
GTXI Score:
-80.82
Program for mitigation of prostate problems (including cancer) appears to be on track and shows great promise. This stock has no middle ground. It will be a ten bagger or out of business in 5 yrs.
Recs
LesMiles
(41.98)
Submitted: 5/30/2006 10:13:55 PM :
Start Price:
$8.57
GTXI Score:
-75.89
2 drugs (same drug @ different doses for different effects) in phase iii trials and 1 drug just starting
phase ii trial with another candidate waiting in the wings.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 21 - 24 of 24 : « Previous 1 2